For research use only. Not for therapeutic Use.
Vibozilimodum (Cat No.: I038040) is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator developed for the treatment of autoimmune and inflammatory diseases such as multiple sclerosis and inflammatory bowel disease. By targeting S1P1 receptors, Vibozilimodum reduces lymphocyte egress from lymph nodes, thereby lowering immune cell infiltration into inflamed tissues. It offers strong immunomodulatory effects with improved safety and selectivity compared to earlier S1P modulators. Vibozilimodum is a promising candidate for managing chronic immune-mediated disorders and advancing targeted immunotherapy research.
| CAS Number | 1403232-33-6 |
| Synonyms | vibozilimodum; vibozilimod |
| Molecular Formula | C29H36ClN3O5 |
| Purity | 98% |
| Target | LPL Receptor |
| Solubility | To be determined |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 1-[(4-{5-[3-chloro-4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl}phenyl)methyl]-4-[(2-methoxyethoxy)methyl]piperidine-4-carboxylic acid |
| InChI | InChI=1S/C29H36ClN3O5/c1-20(2)16-23-8-9-24(17-25(23)30)27-31-26(32-38-27)22-6-4-21(5-7-22)18-33-12-10-29(11-13-33,28(34)35)19-37-15-14-36-3/h4-9,17,20H,10-16,18-19H2,1-3H3,(H,34,35) |
| InChIKey | LIVCREVOSRJFDS-UHFFFAOYSA-N |
| SMILES | O=C(C1(COCCOC)CCN(CC2=CC=C(C3=NOC(C4=CC=C(CC(C)C)C(Cl)=C4)=N3)C=C2)CC1)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
